Invention Grant
- Patent Title: Carbidopa and L-dopa prodrugs and methods of use
- Patent Title (中): 卡比多巴和左旋多巴前药及其使用方法
-
Application No.: US14919418Application Date: 2015-10-21
-
Publication No.: US09446059B2Publication Date: 2016-09-20
- Inventor: Benoit Cardinal-David , Vincent S. Chan , Kassibla E. Dempah , Brian P. Enright , Rodger F. Henry , Raimundo Ho , Ye Huang , Alexander D. Huters , Russell C. Klix , Scott W. Krabbe , Philip R. Kym , Yanbin Lao , Xiaochun Lou , Sean E. Mackey , Mark A. Matulenko , Peter T. Mayer , Christopher P. Miller , James Stambuli , Eric A. Voight , Zhi Wang , Geoff G. Zhang , Valentino J. Stella
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Harness, Dickey & Pierce, P.L.C.
- Main IPC: A61K31/661
- IPC: A61K31/661 ; C07F9/06 ; A61K31/6615
Abstract:
The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease.
Public/Granted literature
- US20160106765A1 Carbidopa and L-Dopa Prodrugs and Methods of Use Public/Granted day:2016-04-21
Information query
